To include your compound in the COVID-19 Resource Center, submit it here.

Medivir infectious news

Medivir said it is discontinuing its preclinical HCV NS5A protein inhibitor program

Read the full 127 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE